Legaspi, Marilyn .
HRN: 23-97-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2023
CEFUROXIME 500MG (TAB)
11/18/2023
11/25/2023
PO
500 Mg
BID
S/P LSCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes